Regulation of Angiogenesis During Wound Healing
伤口愈合过程中血管生成的调节
基本信息
- 批准号:6470128
- 负责人:
- 金额:$ 29.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-06-01 至 2006-05-31
- 项目状态:已结题
- 来源:
- 关键词:angiogenesis angiopoietins basement membrane blood vessels cell migration cell proliferation crosslink gel mobility shift assay gene expression gene targeting genetic regulation genetic regulatory element genetically modified animals homeostasis in situ hybridization laboratory mouse messenger RNA microinjections posttranscriptional RNA processing protein tyrosine kinase reporter genes tissue /cell culture transcription factor vascular endothelium vascular smooth muscle wound healing
项目摘要
Description (provided by applicant): Wound healing requires the formation of
new vasculature in a complex process that is dependent on stabilization and
destabilization signals. The endothelial cell-specific receptor tyrosine
kinase, Tie2, when stimulated by its primary ligand, angiopoietin-1 (Ang1),
promotes blood vessel stability by stimulating cell viability, basement
membrane integrity, and perivascular cell recruitment. Ang2, an antagonist of
the Tie2 receptor, blocks these signals by competing for Ang1 binding, and is
necessary for the locaiized vessel instability associated with angiogenesis.
Thus, the ratio of Ang1 to Ang2 is a critical factor in the regulation of
neovascularization; altering Ang1 or Ang2 expression can lead to profound
vascular defects. This study focuses on evidence that Ang2 expression is
regulated post-transcriptionally; endothelial and smooth muscle cell culture
models demonstrate profound changes in Ang2 mRNA half-life in response to
certain growth factors. This induced change in message stability is dependent
on new transcription, presumably of factors associated with regulated mRNA
turnover. It is hypothesized that such post-traiascriptional regulation is
critical for the maintenance of appropriate Ang2 levels during tissue repair.
To test this, the putative mRNA control elements within the human, mouse, and
rat Ang2 MRNAs that regulate induced message stability/instability or
translation will be identified and characterized. Their role in regulating Ang2
expression will then be tested in vivo by introducing these elements into
reporter constructs; which will then be used to develop transgenic mice. The
biological roles of these mRNA control elements will be further analyzed in
mice in which these elements are ablated by conditional homologous
recombination. These mouse models will be used to test the effects of
dysfunctional Ang2 post-transcriptional regulation on wound healing. These
studies will indicate the relative importance of post-transcriptional
regulation of Ang2, and whether eliminating the ability of cells to regulate
Ang2 mRNA stability or translation impacts vessel structure during the wound
healing process.
描述(由申请人提供):伤口愈合需要形成
在一个复杂的过程中,新的血管系统依赖于稳定和
不稳定信号内皮细胞特异性受体酪氨酸
激酶Tie 2在其主要配体血管生成素-1(Ang 1)刺激下,
通过刺激细胞活力、基底膜、血管内皮细胞和血管内皮细胞来促进血管稳定性
膜完整性和血管周围细胞募集。Ang 2,一种拮抗剂,
Tie 2受体通过竞争Ang 1结合阻断这些信号,
这是与血管生成相关的局部血管不稳定性所必需的。
因此,Ang 1与Ang 2的比例是调节Ang 1与Ang 2的比例的关键因素。
新血管形成;改变Ang 1或Ang 2表达可导致严重的
血管缺陷这项研究的重点是证据表明,血管生成素2表达是
转录后调节;内皮细胞和平滑肌细胞培养
模型显示Ang 2 mRNA半衰期响应于
某些增长因素。这种信息稳定性的变化依赖于
新的转录,可能是与调节mRNA相关的因子
周转据推测,这种创伤后调节是
这对于在组织修复期间维持适当的Ang 2水平至关重要。
为了测试这一点,在人类、小鼠和哺乳动物中假定的mRNA控制元件被检测到。
调节诱导的信息稳定性/不稳定性的大鼠Ang 2 MRNA,或
翻译将被识别和表征。它们在调节Ang 2中的作用
然后通过将这些元件引入到
报告构建体;然后将其用于开发转基因小鼠。的
这些mRNA控制元件的生物学作用将进一步分析,
小鼠,其中这些元件被条件性同源
重组这些小鼠模型将用于测试
Ang 2对伤口愈合的转录后调节功能失调。这些
研究将表明转录后的相对重要性,
Ang 2的调节,以及是否消除了细胞调节Ang 2的能力,
Ang 2 mRNA的稳定性或翻译在创伤期间影响血管结构
愈合过程
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC W HOWARD其他文献
ERIC W HOWARD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC W HOWARD', 18)}}的其他基金
Post-Baccalaureate Research and Education Program (PREP) for Oklahoma
俄克拉荷马州学士后研究与教育计划 (PREP)
- 批准号:
10556953 - 财政年份:2023
- 资助金额:
$ 29.79万 - 项目类别:
Regulation of Angiogenesis During Wound Healing
伤口愈合过程中血管生成的调节
- 批准号:
6749041 - 财政年份:2002
- 资助金额:
$ 29.79万 - 项目类别:
Regulation of Angiogenesis During Wound Healing
伤口愈合过程中血管生成的调节
- 批准号:
6616469 - 财政年份:2002
- 资助金额:
$ 29.79万 - 项目类别:
Regulation of Angiogenesis During Wound Healing
伤口愈合过程中血管生成的调节
- 批准号:
6623765 - 财政年份:2002
- 资助金额:
$ 29.79万 - 项目类别:
Regulation of Angiogenesis During Wound Healing
伤口愈合过程中血管生成的调节
- 批准号:
6896096 - 财政年份:2002
- 资助金额:
$ 29.79万 - 项目类别:
ASTACIN PROTEASES, TFG-SIGNALING & EXTRACELLULAR MATRIX
虾红素蛋白酶、TFG 信号传导
- 批准号:
6325796 - 财政年份:2000
- 资助金额:
$ 29.79万 - 项目类别:
REGULATION OF CELL MIGRATION IN VASCULAR REMODELING
血管重塑中细胞迁移的调节
- 批准号:
6184949 - 财政年份:1999
- 资助金额:
$ 29.79万 - 项目类别:
REGULATION OF CELL MIGRATION IN VASCULAR REMODELING
血管重塑中细胞迁移的调节
- 批准号:
2826076 - 财政年份:1999
- 资助金额:
$ 29.79万 - 项目类别:
REGULATION OF CELL MIGRATION IN VASCULAR REMODELING
血管重塑中细胞迁移的调节
- 批准号:
6390276 - 财政年份:1999
- 资助金额:
$ 29.79万 - 项目类别:
REGULATION OF CELL MIGRATION IN VASCULAR REMODELING
血管重塑中细胞迁移的调节
- 批准号:
6527402 - 财政年份:1999
- 资助金额:
$ 29.79万 - 项目类别:
相似国自然基金
益肺清化颗粒对血管生成因子及VEGF/KDR和Angiopoietins /Tie2信号传导通路的调控作用研究
- 批准号:30973841
- 批准年份:2009
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
- 批准号:
10301502 - 财政年份:2021
- 资助金额:
$ 29.79万 - 项目类别:
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
- 批准号:
10487563 - 财政年份:2021
- 资助金额:
$ 29.79万 - 项目类别:
Evaluation of Angiopoietins as Prognostic Markers of Kidney Allograft Structure and Function
血管生成素作为肾同种异体移植结构和功能的预后标志物的评价
- 批准号:
10626144 - 财政年份:2021
- 资助金额:
$ 29.79万 - 项目类别:
Differential agonistic activities of angiopoietins on neutrophils
血管生成素对中性粒细胞的差异激动活性
- 批准号:
304873 - 财政年份:2014
- 资助金额:
$ 29.79万 - 项目类别:
Operating Grants
The Role of Angiopoietins 1 and 2 in ANCA Associated Vasculitis
血管生成素 1 和 2 在 ANCA 相关性血管炎中的作用
- 批准号:
MR/K000977/1 - 财政年份:2013
- 资助金额:
$ 29.79万 - 项目类别:
Fellowship
Expression and functional roles of angiopoietins in lymphangiogenesis and development of lymphatic induction system
血管生成素在淋巴管生成和淋巴诱导系统发育中的表达和功能作用
- 批准号:
21590217 - 财政年份:2009
- 资助金额:
$ 29.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Agonistic activities of angiopoietins on neutrophils
血管生成素对中性粒细胞的激动活性
- 批准号:
181135 - 财政年份:2009
- 资助金额:
$ 29.79万 - 项目类别:
Operating Grants
Elucidation of molecular mechanisms of angiogenesis mediated by angiopoietins and its application for asthma therapy
阐明血管生成素介导的血管生成的分子机制及其在哮喘治疗中的应用
- 批准号:
20590901 - 财政年份:2008
- 资助金额:
$ 29.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Regulation of skeletal muscle injury and regeneration by angiopoietins
血管生成素对骨骼肌损伤和再生的调节
- 批准号:
171081 - 财政年份:2008
- 资助金额:
$ 29.79万 - 项目类别:
Operating Grants
The Role of Tie2 and the Angiopoietins in EPC Biology
Tie2 和血管生成素在 EPC 生物学中的作用
- 批准号:
6999609 - 财政年份:2005
- 资助金额:
$ 29.79万 - 项目类别:














{{item.name}}会员




